| 期 |
标题 |
文件 |
| 卷 80, 编号 1 (2025) |
The impact of gut microbiota on colorectal cancer development |
(Rus)
|
|
Davydova O., Lichman L., Andreev P., Katorkin S., Stanina U., Kondratieva S., Kaiumov K., Lyamin A.
|
| 卷 79, 编号 6 (2024) |
The set of PCR-based laboratory methods for molecular diagnostics in oncology |
(Rus)
|
|
Dribnokhodova O., Mironov K., Pozdysheva E., Vinokurov M., Korchagin V., Akimkin V.
|
| 卷 79, 编号 6 (2024) |
Genetic and epigenetic predictors of tongue squamous cell carcinoma sensitivity to platinum drugs |
(Rus)
|
|
Kit O., Engibaryan M., Gvaramiya A., Volkova V., Chertova N., Kutilin D.
|
| 卷 79, 编号 6 (2024) |
Analysis of global practices in CAR-T cell production organization and an example of implementation at the Dmitry Rogachev National Medical Research Center for Pediatric Hematology, Oncology, and Immunology |
(Rus)
|
|
Badrin E., Maschan M., Pershin D., Pyatigorskaya N.
|
| 卷 79, 编号 4 (2024) |
An Analytical Study of the Recommendations for Molecular Genetic Testing in the Russian and Foreign Clinical Guidelines for Non-Small Cell Lung Cancer |
(Rus)
|
|
Omelyanovsky V., Ryzhov A., Ledovskih Y.
|
| 卷 79, 编号 3 (2024) |
Clinical Value of Stromal Cell Factor (Sdf-1) Determination in Chemotherapy-Induced Peripheral Polyneuropathy in Patients with Hematological Malignancies (Results of a Prospective Cohort Study) |
(Rus)
|
|
Kovtun O., Bazarnyi V., Koryakina O., Kopenkin M.
|
| 卷 79, 编号 2 (2024) |
Еffect of Radiation Therapy on Breast Reconstruction in Breast Cancer Patients |
(Eng)
|
|
Shirokikh I., Khakimova G., Zikiryakhodzhaev A., Khakimova S.
|
| 卷 79, 编号 2 (2024) |
Retrospective Cross-Sectional Epidemiological Study of Human Papillomavirus-Associated Precancers and Anogenital Warts in Patients Attending Specialized Clinics in Russian Federation |
(Rus)
|
|
Briko N., Lopukhov P., Zarochentseva N., Baranov I., Kachalina O., Ziganshin O., Shuldyakov A.
|
| 卷 78, 编号 6 (2023) |
Comparative Evaluation of the Results of Radical Surgical Treatment of Patients with Muscle-Invasive Bladder Cancer |
(Rus)
|
|
Startsev V., Sarychev S., Tyapkin N., Kondratiev G.
|
| 卷 78, 编号 1 (2023) |
Antiaging Klotho Protein as a Prospective Novel Tumor Suppressor |
(Rus)
|
|
Nesterova K., Glinka Y., Perfilova V., Nesterova A., Kaplanov K.
|
| 卷 77, 编号 6 (2022) |
Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part II. Hematological Markers of Inflammation |
(Rus)
|
|
Sergeeva N., Karmakova T., Polyak M., Alentov I.
|
| 卷 77, 编号 6 (2022) |
99mTc-Labelled Low Molecular Weight Inhibitors of Prostate-Specific Membrane Antigen |
(Rus)
|
|
Tishchenko V., Petriev V., Vlasova O., Pankratov A., Morozova N., Shegai P., Ivanov S., Kaprin A.
|
| 卷 77, 编号 5 (2022) |
Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part I. Tumor-Promoting Inflammation. Serum Inflammatory Markers |
(Rus)
|
|
Sergeeva N., Karmakova T., Polyak M., Alentov I., Kaprin A.
|
| 卷 77, 编号 3 (2022) |
The Role of Molecular Genetic Studies in Current Oncology |
(Rus)
|
|
Kit O., Maksimov A., Jenkova E., Timoshkina N.
|
| 卷 77, 编号 3 (2022) |
Main Scientific Directions of Oncology Development in the Republic of Tatarstan |
(Rus)
|
|
Hasanov R., Akhmedova G., Karpenko L., Gataullin I.
|
| 卷 76, 编号 6 (2021) |
Trends in Morbidity and Hospital Lethality from Neoplasms before and during the New Coronavirus Infection COVID-19 |
(Rus)
|
|
Starodubov V., Stupak V., Manoshkina E., Son I.
|
| 卷 76, 编号 5 (2021) |
Risk Factors in Cancer Patients |
(Rus)
|
|
Slukhanchuk E., Bitsadze V., Tyan A., Khizroeva J., Tretyakova M., Solopova A., Muyang M., Elalamy I., Gris J., Ay C., Makatsaria A.
|
| 卷 76, 编号 3 (2021) |
Innovative Approach to Surgical Treatment for Locally Advanced Cancer of Paranasal Sinus and Nasal Cavity |
(Rus)
|
|
Kit O., Reshetov I., Engibaryan M.
|
| 卷 75, 编号 4 (2020) |
Cancer treatment and research in the context of COVID-19 pandemic: the experience of foreign countries |
(Rus)
|
|
Kit O., Gevorkyan Y., Soldatkina N., Gevorkyan E.
|
| 1 - 19 的 19 信息 |
|
